Trial Profile
Exenatide and Postprandial Endothelial Dysfunction: Effects and Mechanisms.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Exenatide (Primary) ; Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 09 Jun 2015 Results (substudy 1, n=36) presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
- 19 Jan 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 03 Sep 2010 New trial record